2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-Year experience in Poland

European Journal of Haematology

Volumn 62, Issue 1, 1999, Pages 49-56

  Robak, Tadeusz ⁱ   Blasinska Morawiec M ^j   Blonski J ^j   Hellmann, A ^j   Halaburda K ^j   Konopka, L ^a   Kotlarek Haus, S ^b   Potoczek, S ^b   Hansz, J ^c   Dmoszynska A ^d   Urasinski I ^e   Zdziarska, B ^e   Dwilewicz Trojaczek, J ^f   Holowiecki J ^g   Skotnicki, A B ^h  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b Academy of Medicine   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

^g MEDICAL UNIVERSITY OF SILESIA   (Poland)

^h JAGIELLONIAN UNIVERSITY   (Poland)

ⁱ MEDICAL UNIVERSITY OF LODZ   (Poland)

^j NONE

more..

Author keywords

2 chlorodeoxyadenosine; Efficiency; Hairy cell leukemia; Hairy cell leukemia variant; Relapse; Second neoplasm; Side effects

Indexed keywords

ALPHA INTERFERON; CHLORAMBUCIL; CLADRIBINE; PREDNISONE;

ADULT; AGED; ARTICLE; CELL SURVIVAL; DRUG EFFECT; DRUG EFFICACY; EXPERIENCE; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MONONUCLEAR CELL; POLAND; PRIORITY JOURNAL; RELAPSE; SPLENECTOMY;

EID: 0032932661     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01114.x     Document Type: Article

References (43)

1. NAEIM F. Hairy cell leukemia. Characteristics of the neoplastic cells. Hum Pathol 1987;19:375-388.
2. CHANG KL, STROUP R, WEISS LW. Hairy cell leukemia - current status. Am J Clin Pathol 1992;97:719-738.
3. PLATANIAS LC, GOLOMB HM. Hairy cell leukaemia. Ballière's Clin Haematol 1993;6:887-898.
4. CAWLEY JC, BURNS GF, HAYHOE FG. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia. Leuk Res 1980;4:547-559.
5. CATOVSKY D, O'BRIEN M, MELO JV, VARDLE J, BROZOVIC M. Hairy cell leukemia variant. An intermediate disease between hairy cell leukemia and prolymphocytic leukemia. Semin Oncol 1984;11:363-369.
6. DIEZ JL, LI CY, BANKS PM. Blastic variant of hairy cell leukemia. Am J Clin Pathol 1987;87:576-583.
7. HANSON CA, WARD PC, SCHNITZER B. A multilobular variant of hairy cell leukemia with morphologic similarities to T-cell lymphoma. Am J Surg Pathol 1989;13:671-679.
8. SUN T, SUSIN M, SHEVDE N, TEICHBERG S. Hybrid form of hairy cell leukemia and chronic lymphocytic leukemia. Hematol Oncol 1990;8:283-294.
9. SPIERS AS, MOORE D, CASSILETH PA, et al. Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin). N Engl J Med 1987;316:825-830.
10. PIRO LD, CARRERA CJ, CARSON DL, BEUTLER E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117-1121.
11. SAVEN A, PIRO L. Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med 1994;330:691-697.
12. PIRO LD, MILLER WE, CARRERA CJ, CARSON DA, BEUTLER E. Hairy-cell leukemia. N Engl J Med 1987;317:901.
13. SAVEN A, PIRO LD. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia. Cancer Invest 1993;11:559-564.
14. PIRO LD, SAVEN A, ELLISON D, et al. Prolonged complete remissions following 2-chlorodeoxyadenosine (2-CdA) in hairy cell leukemia (HCL). Proc Am Soc Clin Oncol 1992;11:259 (abstract).
15. JULIUSSON G, LILIEMARK J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′deoxyadenosine (CdA): relation to opportunistic infections. Blood 1992;79:888-894.
16. ROBAK T, BŁASIǸSKA-MORAWIEC M, KRYKOWSKI E, et al. 2-Chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leuk Lymph 1996;22:107-111.
17. LILIEMARK J, JULIUSSON G. On the pharmacokinetics of 2-chloro-2-deoxyadenosine in humans. Cancer Res 1991;51:55 70-72.
18. SAVEN A, CHEUNG WK, SMITH I, et al. Pharmacokinetic study of oral bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy. J Clin Oncol 1996;14:978-983.
19. FAYAD L, KURZROCK R, KEATING M, et al. Treatment of hairy-cell leukemia (HCL) with 2-CdA. Long term follow-up at M.D. Anderson Cancer Center. Blood 1997;90(suppl.1 Part 2) 530a (abstr. 2363).
20. TALLMAN MS, HAKIMIAN D, RADEMAKER AW, et al. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood 1996;88:1954-1959.
21. HOFFMAN MA, JANSON D, ROSE E, RAI KR. Treatment of hairy-cell leukemia with cladribine: response toxicity and long-term follow-up. J Clin Oncol 1997;15:1138-1142.
22. JANSEN J, HERMANS JF for the Collaborative Study Group. Splenectomy in hairy cell leukemia. A retrospective multicenter analysis. Cancer 1981;47:2066-2076.
23. GOLOMB HM, FEFER A, GOLDE DW, et al. Report of a multiinstitutional study of 193 patients with hairy cell leukemia treated with interferon alpha 2B. Semin Oncol 1988;15:7-9.
24. BLASIǸSKA-MORAWIEC M, ROBAK T, KRYKOWSKI E, et al. Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine - a report of three cases. Leuk Lymph 1997;25:381-385.
25. KAZIMIERCZUK Z, VILPO J, HILDEBRAND C, WRIGHT G. Synthesis and cytotoxicity of deoxyadenosine analogues: isomer distribution in the sodium salt glycosylation of 2,6-disubstituted purines. J Med Chem 1990;33:1683-1687.
26. OKEN MM, CREECH R, TORMEY DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
27. KAPLAN EL, MEIER P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
28. KRAUT E, GREVER MR, BOURONCLE BA. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood 1994;84:4061-4063.
29. CATOVSKY D, MATUTES E, TALAVERA JG, et al. Long term results with 2′-deoxycoformycin in hairy cell leukemia. Leuk Lymph 1994;14:109-113.
30. ESTEY EH, KURZOCK R, KANTARIJAN HM, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 1992;79:882-887.
31. + lymphocyte counts in patients with hairy cell leukemia. Blood 1994;83:2906-2911.
32. LAURIA F, RONDELLI D, ZINZANI PL, et al. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey. Leukemia 1997;11:629-632.
33. CARBONE A, REATO G, DI CELLE PF, et al. Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia 1994;8:2019-2021.
34. KONWALINKA G, SCHIRMER M, HILBE W, et al. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine. Blood Cells Mol Dis 1995;21:142-151.
35. FILLEUL B, DELANNOY A, FERRANT A, et al. A single courses of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 1994;8:1153-1156.
36. WHEATON S, TALLMAN MS, HAKIMIAN D, PETERSON LA. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlrodeoxoxyadenosine. Blood 1996;87:1556-1560.
37. THALER J, GRUNEWALD K, GATTRINGER C, et al. Long-term follow-up of patients with hairy cell leukemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration. Br J Hematol 1993;84:75-82.
38. POLLIACK A, DAMN EJ. Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlroodeoxyadenosine therapy: the spleen as a sanctuary site in HCL? Blood 1994;83:2057-2058.
39. SAINATI L, MATUTES E, MULLIGAN S, et al. A variant form of hairy cell leukemia resistant to α interferon: clinical phenotypic characteristics of 17 patients. Blood 1990;76:157-162.
40. ROBAK T, BŁASIǸSKA-MORAWIEC M, KRYKOWSKI E, et al. The effect of 2-hour infusion of 2-chlorodeoxyadenosine (cladribine) with prednison in previously untreated B-cell chronic lymphocytic leukemia. Eur J Cancer 1997;33:2347-2351.
41. ROBAK T, BŁASIǸSKA-MORAWIEC M, KRYKOWSKI E, et al. 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative disease. Eur J Haematol 1997:216-220.
42. TALLMAN MS, HAKIMIAN D, VARIAKOJIS D, et al. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992;80:2203-2209.
43. KAMPMEIER P, SPIELBERGER R, DICKSTEIN J, et al. Increased incidence of second neoplasms in patients treated with interferon α 2b for hairy cell leukemia: a clinicopathologic assessment. Blood 1994;83:2931-2938.